Phase 2 Trial Evaluating Biodistribution and Shedding of Talimogene Laherparepvec (T-VEC) in Patients (Pts) with Unresectable Stages IIIB/IV MelanomaRobert H. I. Andtbacka,Janice Mehnert,John J. Nemunaitis,John Walker,Jason Chesney,Jonathan S. Zager,Yang Zhang,Swami Murugappan,Thomas AmatrudaMOLECULAR THERAPY(2017)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要